BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zarębska-Michaluk D. Genotype 3-hepatitis C virus’ last line of defense. World J Gastroenterol 2021; 27(11): 1006-1021 [PMID: 33776369 DOI: 10.3748/wjg.v27.i11.1006]
URL: https://www.wjgnet.com/1007-9327/full/v27/i11/1006.htm
Number Citing Articles
1
Priyanka Shukla Bajpai, Laura Collignon, Christina Sølund, Lone Wulff Madsen, Peer Brehm Christensen, Anne Øvrehus, Nina Weis, Kenn Holmbeck, Ulrik Fahnøe, Jens Bukh, J.-H. James Ou. Full-length sequence analysis of hepatitis C virus genotype 3b strains and development of an in vivo infectious 3b cDNA clone Journal of Virology 2023; 97(12) doi: 10.1128/jvi.00925-23
2
Anna Piekarska, Aleksandra Berkan-Kawińska, Hanna Berak, Włodzimierz Mazur, Marek Sitko, Anna Parfieniuk-Kowerda, Beata Lorenc, Dorota Dybowska, Ewa Janczewska, Justyna Janocha-Litwin, Beata Dobracka, Łukasz Socha, Magdalena Tudrujek-Zdunek, Robert Flisiak. Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patientsExpert Review of Anti-infective Therapy 2024; : 1 doi: 10.1080/14787210.2024.2353691
3
Wesal Elgretli, Tianyan Chen, Nadine Kronfli, Giada Sebastiani. Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical ImpactBiomedicines 2023; 11(2): 271 doi: 10.3390/biomedicines11020271
4
Jennifer J. Lin, Catrina M. Loucks, Jessica N. Trueman, Britt I. Drögemöller, Galen E.B. Wright, Eric M. Yoshida, Jo-Ann Ford, Samuel S. Lee, Richard B. Kim, Bandar Al-Judaibi, Ute I. Schwarz, Alnoor Ramji, Edward Tam, Colin J. Ross, Bruce C. Carleton. Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatmentBiomedicine & Pharmacotherapy 2021; 143: 112195 doi: 10.1016/j.biopha.2021.112195
5
Ligita Jančorienė, Baiba Rozentāle, Ieva Tolmane, Agita Jēruma, Riina Salupere, Arida Buivydienė, Jonas Valantinas, Limas Kupčinskas, Jolanta Šumskienė, Eglė Čiupkevičienė, Arvydas Ambrozaitis, Olga Golubovska, Larysa Moroz, Robert Flisiak, Borys Bondar. Genotype Distribution and Characteristics of Chronic Hepatitis C Infection in Estonia, Latvia, Lithuania, and Ukraine: The RESPOND-C StudyMedicina 2023; 59(9): 1577 doi: 10.3390/medicina59091577
6
Ru Xu, Xia Rong, Elihu Aranday-Cortes, Sreenu Vattipally, Joseph Hughes, John McLauchlan, Yongshui Fu. The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolutionary Kinetics and Selective Force AnalysisViruses 2022; 14(7): 1514 doi: 10.3390/v14071514
7
Shuang Zhou, Karen Qi, Susan J. Bersoff‐Matcha, Poonam Mishra, Kimberly Struble. Sex‐related difference analyses of efficacy and safety in clinical trials of direct‐acting antivirals to treat chronic HCV genotype 1 and 3 infectionsJournal of Viral Hepatitis 2024; 31(2): 78 doi: 10.1111/jvh.13901
8
Hsuan-Yu Hung, Hui-Hsiung Lai, Hui-Chuan Lin, Chung-Yu Chen. The impact of sofosbuvir/velpatasvir/voxilaprevir treatment on serum hyperglycemia in hepatitis C virus infections: a systematic review and meta-analysisAnnals of Medicine 2023; 55(1): 463 doi: 10.1080/07853890.2023.2168745
9
Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, Ewa Janczewska, Dorota Dybowska, Małgorzata Pawłowska, Waldemar Halota, Włodzimierz Mazur, Beata Lorenc, Justyna Janocha-Litwin, Krzysztof Simon, Anna Piekarska, Hanna Berak, Jakub Klapaczyński, Piotr Stępień, Barbara Sobala-Szczygieł, Jolanta Citko, Łukasz Socha, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Marek Sitko, Beata Dobracka, Rafał Krygier, Jolanta Białkowska-Warzecha, Łukasz Laurans, Robert Flisiak. Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected CirrhoticsJournal of Clinical Medicine 2021; 10(15): 3280 doi: 10.3390/jcm10153280
10
Jing Zhou, Fa-Da Wang, Lan-Qing Li, Jing-Yu Li, En-Qiang Chen. Decreased Efficacy of Sofosbuvir/Velpatasvir in HIV Patients Coinfected with HCV Genotype 3bFuture Virology 2024; 19(1): 33 doi: 10.2217/fvl-2023-0112